Management of Klinefelter Syndrome

Diagnosis and Initial Evaluation

Klinefelter syndrome is characterized by a 47,XXY karyotype and is the most common sex chromosomal disorder in humans, with clinical features including small testes, hypogonadism, and azoospermia in >90% of cases 1, 2
Genetic testing is essential for diagnosis, with karyotype analysis recommended for patients with azoospermia or severe oligospermia, and the European Urology society recommends this approach 3
Y-chromosome microdeletion analysis should also be performed as part of the genetic workup, although this fact is from Praxis Medical Insights, a similar recommendation is found in other sources 4

Hormonal evaluation should include measurement of serum total testosterone, follicle-stimulating hormone (FSH), and luteinizing hormone (LH), as recommended by the European Urology society 3, 4

Testicular sperm extraction (TESE) can retrieve sperm in 20-50% of men with Klinefelter syndrome, and the European Urology society recommends this approach 3
Fertility preservation should be discussed early, as sperm retrieval rates may be higher in younger patients, according to the Human Reproduction Update society 1

Patients with Klinefelter syndrome have an increased risk of breast cancer compared to the general male population, and should be monitored for this condition, as recommended by Praxis Medical Insights, however a similar recommendation is found in other sources 5

Genetic counseling should be offered to patients and their families, as recommended by the Kidney International society 6

Patients should be informed that Klinefelter syndrome may be discovered incidentally during pharmacogenomic testing, as noted by the Annual Review of Genomics and Human Genetics society 7

The European Urology guidelines recommend measuring follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels, which are typically elevated in Klinefelter syndrome, before initiating treatment 8
Testicular sperm extraction (TESE) should be offered to men with Klinefelter syndrome desiring biological children, with a success rate of 20-50%, and discussed early, ideally before or shortly after initiating testosterone therapy 8
The European Urology guidelines also state that testosterone therapy does not improve fertility and may further suppress spermatogenesis 8

The American College of Cardiology recommends screening for congenital heart defects, present in 50% of cases, particularly patent ductus arteriosus (PDA) and atrial septal defect (ASD), in patients with Klinefelter syndrome 9